The amyloid precursor protein of Alzheimer's disease and the Aβ peptide

Neuropathology and Applied Neurobiology

Volumn 25, Issue 2, 1999, Pages 81-97

  Storey, E ^a,c   Cappai, R ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

Aggregation; Genetic transmission; Heparin binding; Neurotoxicity; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; COPPER; HEPARIN BINDING PROTEIN; MEMBRANE PROTEIN; PRESENILIN 1; PRESENILIN 2; TAU PROTEIN; ZINC;

ALZHEIMER DISEASE; BLOOD VESSEL WALL; CELL STRUCTURE; CELL TRANSPORT; COGNITIVE DEFECT; GENE MUTATION; HEMOSTASIS; HUMAN; METAL BINDING; MOLECULAR BIOLOGY; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PAIRED HELICAL FILAMENT; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN SECRETION; REVIEW; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032902647     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1999.00164.x     Document Type: Review

References (202)

1. 1 Asami-Odaka A, Ishibashi Y, Kikuchi T, Kitada C, Suzuki N. Long amyloid β-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry 1995; 34: 10272-8
2. 2 Barger SW, Fiscus RR, Ruth P, Hofmann F, Mattson MP. Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of b-amyloid precursor. J Neurochem 1995; 64: 2087-96
3. 3 Barger SW, Mattson MP. Induction of neuroprotective kB-dependent transcription by secreted forms of the Alzheimers b-amyloid precursor. Mol Brain Res 1996; 40: 116-26
4. 4 Beher D, Hesse L, Masters CL, Multhaup G. Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I. J Biol Chem 1996; 271: 13-20
5. 5 Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994; 77: 817-27
6. 6 Beyreuther K, Multhaup G, Monning U et al. Regulation of APP expression, biogenesis and metabolism by extracellular matrix and cytokines. Ann NY Acad Sci 1996; 777: 74-6
7. 7 Bird TD, Lampe TH, Nemens ET, Miner GW, Sumi SM, Schellenberg GD. Familial Alzheimer's disease in American descendants of the Volga Germans: probable genetic founder effect. Ann Neurol 1988; 23: 25-31
8. 8 Borchelt DR, Thinakaran G, Eckman CB et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 1996; 17: 1005-13
9. 9 Bornebrock M, Haan J, Maat-Schieman MLC, Van Duinen SG, Roos RAC. Hereditary cerebral haemorrhage with amyloidosis-Dutch type (HCHWA-D): I - a review of clinical, radiologic and genetic aspects. Brain Pathol 1996; 6: 111-4
10. 10 Burdick D, Soreghan B, Kwon M et al. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J Biol Chem 1992; 267: 546-54
11. 11 Busciglio J, Lorenzo A, Yeh J, Yankner BA. β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995; 14: 879-88
12. 12 Bush AI, Multhaup G, Moir RD et al. A novel zinc (II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. J Biol Chem 1993; 268: 16109-12
13. 13 Bush AI, Pettingell WH, Multhaup G et al. Rapid induction of Alzheimer Aβ amyloid formation by Zinc. Science 1994; 265: 1464-7
14. 14 Bush AI, Pettingell WJ, de Paradis M, Tanzi RE, Wasco W. The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily. J Biol Chem 1994; 269: 26618-21
15. 15 Butterfield DA, Hensley K, Harris M, Mattson M, Carney J. β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-sperific fashion: implications to Alzheimer's disease. Biochem Biophys Res Commun 1994; 200: 710-5
16. 16 Buxbaum JD, Gandy SE, Cicehetti P et al. Processing of Alzheimer β/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci USA 1990; 87: 6003-6
17. 17 Buxbaum JD, Greengard P. Regulation of APP processing by intra-and intercellular signals. Ann NY Acad Sci 1996; 777: 327-31
18. 18 Buxbaum JD, Ruefli AA, Parker CA, Cypess AM, Greengard P. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proc Natl Acad Sci USA 1994; 91: 4489-93
19. 19 Cai X-D, Golde TE, Younkin SG. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 1993; 259: 514-6
20. 20 Campion D, Brice A, Hannequin D et al. No founder effect in three novel Alzheimer's disease families with APP. 717 Valα(r) Ile mutation. J Med Genet 1996; 33: 661-4
21. 21 Caporaso GL, Gandy SE, Buxbaum JD, Greengard P. Chloroquine inhibits intracellular degradation but not secretion of Alzheimer β/A4 amyloid precursor protein. Proc Natl Acad Sci USA 1992; 89: 2252-6
22. 22 Citron M, Oltersdorf T, Haass C et al. Mutation of the β-amyloid protein in familial Alzheimer's disease increases β-protein production. Nature 1992; 360: 672-4
23. 23 Citron M, Teplow DB, Selkoe DJ. Generation of amyloid beta protein from its precursor is sequence specific. Neuron 1995; 14: 661-70
24. 24 Citron M, Diehl TS, Capell A, Haass C, Teplow DB, Selkoe DJ. Inhibition of amyloid β-protein production in neural cells by the serine protease inhibitor AEBSF. Neuron 1996; 17: 171-9
25. 25 Citron M, Diehl TS, Gordon G, Biere AL, Seubert P, Selkoe DJ. Evidence that the 42-and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activities. Proc Natl Acad Sci USA 1996; 93: 13170-5
26. 26 Citron M, Westaway D, Xia W et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat Med 1997; 3: 67-72
27. 27 Clarris HJ, Cappai R, Heffernan D, Beyreuther K, Masters CL, Small DH. Identification of heparin-binding domains in the amyloid precursor protein of Alzheimer's disease by deletion mutagenesis and peptide mapping. J Neurochem 1997; 68: 1164-72
28. 28 Cole GJ, Glaser L. A heparin-binding domain from N-CAM is involved in neural cell-substratum adhesion. J Cell Biol 1986; 102: 403-12
29. 29 Cook DG, Sung JC, Golde TE et al. Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. Proc Natl Acad Sci USA 1996; 93: 9223-8
30. 30 Cook DG, Forman MS, Sung JC et al. Alzheimer's Aβ (1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nature Med 1997; 3: 1021-3
31. 31 Crook R, Verkkoniemi A, Perez-Tur J et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nature Med 1998; 4: 452-5
32. 32 da Cruz e Silva OA, Iverfeldt K, Oltersdorf T et al. Regulated cleavage of Alzheimer β-amyloid precursor protein in the absence of the cytoplasmic tail. Neuroscience 1993; 57: 873-7
33. 33 Daigle I, Li C. apl-1, a Caenorhabditis elegans gene encoding a protein related to the human beta-amyloid protein precursor. Proc Natl Acad Sci USA 1993; 90: 12045-9
34. 34 De Strooper B, Saftig P, Craessaerts K et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998; 391: 387-90
35. 35 Doan A, Thinakaran G, Borchelt DR et al. Protein topology of presenilin 1. Neuron 1996; 17: 1023-30
36. 36 Duff K, Eckman C, Zehr C et al. Increased Amyloid-β in brains of mice expressing mutant presenilin 1. Nature 1996; 42: 710-3
37. 37 Duff K. Transgenic models for Alzheimer's disease. Neuropathol Appl Neurobiol 1998; 24: 101-3
38. 38 Eckman CB, Mehta ND, Crook R et al. A new pathogenic mutation in the APP gene (1716V) increases the relative proportion of A β 42 (43). Hum Mol Genet 1997; 6: 2087-9
39. 39 Esch FS, Keim PS, Beattie EC et al. Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 1990; 248: 1122-4
40. 40 Estus S, Golde TE, Kunishita T et al. Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 1992; 255: 726-8
41. 41 Franceschi C, Chiricolo M, Licastro F et al. Oral zinc supplementation in Down's syndrome: restoration of thymic endocrine activity and of some immune defects. J Ment Defic Res 1988; 32: 169-81
42. 42 Fraser PE, Nguyen JT, Chin DT, Kirschner DA. Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions. J Neurochem 1992; 59: 1531-40
43. 43 Frederickson CJ. Neurobiology of zinc and zinc-containing neurons. Int Rev Neurobiol 1989; 31: 145-238
44. 44 Fukumoto H, Asami-Odaka A, Suzuki N, Shimada H, Ihara Y, Iwatsubo T. Amyloid β-protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. Predominance Aβ and association of Aβ40 with cored plaques. Am J Path 1996; 148: 259-65
45. 45 Fuller SJ, Storey E, Li Q-X, Smith AI, Beyreuther K, Masters CL. Intracellular production of β5A4 amyloid of Alzheimer's disease, modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein. Biochemistry 1995; 34: 8091-8
46. 46 Furukawa K, Sopher BL, Rydel RE et al. Increased activity-regulating and neuroprotective efficacy of a-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J Neurochem 1996; 67: 1882-96
47. 47 Gabuzda D, Busciglio J, Chen LB, Mitsudaira P, Yankner BA. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 1994; 269: 13623-8
48. 48 Geula C, Wu C-K, Saroff D, Lorenzo A, Yuan M, Yankner BA. Aging renders the brain vulnerable to amyloid β-protein neurotoxicily. Nature Med 1998; 4: 827-31
49. 49 Ghiso J, Rostagno A, Gardella JE, Liem L, Gorevic PD, Frangione B. A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion. Biochem J 1992; 288: 1053-9
50. 50 Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120: 885-90
51. 51 Goate A, Chartier-Harlin M-C, Mullan M et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-6
52. 52 Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 1996; 383: 550-3
53. 53 Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 1992; 255: 728-30
54. 54 Goodman Y, Mattson MP. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp Neurol 1994; 128: 1-12
55. 55 Gowing E, Roher AE, Woods AS et al. Chemical characterization of Aβ 17 42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J Biol Chem 1994; 269: 10987-90
56. 56 Gravina SA, Ho L, Eckman CB et al. Amyloid beta protein (Aβ) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ. J Biol Chem 1995;270: 7013-6
57. 57 Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 1992; 357: 500-3
58. 58 Haass C, Schlossmacher MG, Hung AY et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 1992; 359: 322-5
59. 59 Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ. β-amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 1993; 268: 3021-4
60. 60 Haass C, Hung AY, Selkoe DJ, Teplow DJ. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J Biol Chem 1994; 269: 17741-8
61. 1 differentially affects proteolytic processing of mutant and wild-type β-amyloid precusor protein. J Biol Chem 1995; 270: 6186-92
62. 62 Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997; 20: 154-9
63. 4 -dependent glutamate uptake in rat hippocampal astrocyte cultures. J Neurochem 1996; 67: 277-86
64. 64 Hartmann T, Bieger SC, Brühl B et al. Distinct sites of intracellular production for Alzheimer's disease Aβ 40/42 amyloid peptides. Nature Med 1997; 3: 1016-20
65. 65 Hendriks L, van Duijn CM, Cras P et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nature Genet 1992; 1: 218-21
66. 66 Hesse L, Beher D, Masters CL, Multhaup G. The beta A4 amyloid precursor protein binding to copper. FEBS Lett 1994; 349: 109-16
67. 67 Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K. Aggregation and secondary structure of synthetic amyloid βA. 4 peptides of Alzheimer's disease. J Mol Biol 1991; 218: 149-63
68. 68 Holcomb L, Gordon MN, McGowan E et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 1998; 4: 97-100
69. 69 Howlett DR, Jennings KH, Lee DC et al. Aggregation state and neurotoxic properties of Alzheimer β-amyloid peptide. Neurodegeneration 1995; 4: 23-32
70. 70 Hsiao K, Chapman P, Nilsen S et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 1996; 274: 99-102
71. 71 Hutton M, Busfield F, Wragg M et al. Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease. Neuroreport 1996; 7: 801-5
72. 72 Iwatsubo T, Mann DM, Odaka A, Suzuki N, Ihara Y. Amyloid beta protein (A β) deposition: a β precedes A β 40 in Down Syndrome. Ann Neurol 1995; 37: 294-9
73. 73 Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of Aβ42 (43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ. Neuron 1994; 13: 45-53
74. 74 Jacobsen JS. Spruyt MA, Brown AM et al. The release of Alzheimer's disease β-amyloid peptide is reduced by phorbol treatment. J Biol Chem 1994; 269: 8376-82
75. 75 Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE. Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J Biol Chem 1994; 269: 13065-8
76. 76 Jarrett JT, Lansbury PT, Jnr. Seeding 'one-dimensional crystallisation' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993; 73: 1055-8
77. 77 Jarrett JT, Berger EP, Lansbury PT, Jnr. The carboxy terminus of β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993; 32: 4693-7
78. 78 Joachim CL, Duffy LK, Morris JH, Selkoe DJ. Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging. Brain Res 1988; 474: 100-11
79. 79 Kang J, Lemaire H-G, Unterbeck A et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733-6
80. 80 Keller JN, Pang Z, Geddes JW et al. Impairment of glucose and glutamate transport and inducation of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 1997; 69: 273-84
81. 81 Klafki H, Abramowski D, Swoboda R, Paganetti PA, Staufenbiel M. The carboxyl termini of beta-amyloid peptides 1 -40 and 1 -42 are generated by distinct gamma-secretase activities. J Biol Chem 1996; 271: 28655-9
82. 82 Knauer DJ, Thompson JA, Cunningham DD. Protease nexins: cell-secreted proteins that mediate the binding, internalization and degradation of regulatory serine proteases. J Cell Physiol 1983; 117: 385-96
83. 83 Knauer MF, Orlando RA, Glabe CG. Cell surface APP. 751 forms complexes with protease nexin 2 ligands and is internalized via the low density lipoprotein receptor-related protein (LRP). Brain Res 1996; 740: 6-14
84. 1, a selective inhibitor of vaculolar ATPases. J Biol Chem 1995; 270: 2419-22
85. 85 Koh J-Y, Yang LL, Cotman CW. β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 1990; 533: 315-20
86. 86 Komiyama Y, Murakami T, Egawa H, Okubo S, Yasunaga K, Murata K. Purification of factor XIa inhibitor from human platelets. Thromb Res 1992; 66: 397-408
87. 87 Koo EH, Squazzo SL. Evidence that production and release of amyloid β-protein involves the endocytic pathway. J Biol Chem 1994; 269: 17386-9
88. 717 Alzheimer mutation increases the percentage of plasma amyloid-β protein ending at Aβ. Neurology 1997; 48: 741-5
89. 89 Kounnas MZ, Moir RD, Rebeck GW et al. LDL receptor-relaled protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 1995; 82: 331-40
90. 90 Kovacs DM, Fausett HJ, Page KJ et al. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat Med 1996; 2: 224-9
91. 91 Kowall NW, Beal MF, Busciglio J, Duffy LK, Yankner BA. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc Natl Acad Sci USA 1991; 88: 7247-51
92. 92 Kuentzel SL, Ali KM, Altman RA, Greenberg BD, Raub TJ. The Alzheimer β-amyloid protein precursor/protease nexin-II is cleaved by secretase in a trans-Golgi secretory compartment in human neuroglioma cells. Biochem J 1993; 295: 367-78
93. 93 Le Blanc AC, Koutroumanis M, Goodyer CG, Protein Kinase C activation increases release of secreted amyloid precursor protein without decreasing Aβ production in human primary neuronal cultures. J Neurosci 1998; 18: 2907-13
94. 94 Lemere CA, Lopera F, Kosik KS et al. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nature Med 1996; 2: 1146-50
95. 95 Lendon CL, Ashall F, Goate AM. Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 1997; 277: 825-31
96. 96 Levy E, Carman MD, Fernandez-Madrid IJ et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral haemorrhage, Dutch-type. Science 1990; 248: 1124-6
97. 97 Levy-Lahad E, Wasco W, Poorkaj P et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269: 973-7
98. 98 Li J, Ma J, Potter H. Identification and expression analysis of a potential familial Alzheimer disease gene on chromosome 1 related to AD 3. Proc Natl Acad Sci USA 1995; 92: 12180-4
99. 99 Li QX, Berndt MC, Bush AI et al. Membrane-associated forms of the ïïbA4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet. Blood 1994; 84: 113-42
100. 100 Li QX, Evin G, Small DH, Multhaup G, Beyreuther K, Masters CL. Proteolytic processing of Alzheimer's disease beta A. 4 amyloid precursor protein in human platelets. J Biol Chem 1995; 270: 14140-7
101. 101 Li X, Greenwald I. Membrane topology of the C. elegans SEL-12 presenilin. Neuron 1996; 17: 1015-21
102. 102 Lindahl U, Höök M. Glycosaminoglycans and their binding to biological macromolecules. Ann Rev Biochem 1978; 47: 385-417
103. 103 Lorenzo A, Yankner BA. β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci USA 1994; 91: 12243-7
104. 104 Mahdi F, Van Nostrand WE, Schmaier AH. Protease nexin-2 amyloid β-protein precursor inhibits factor Xa in the prothrombinase complex. J Biol Chem 1995; 270: 25468-74
105. 105 Mann DM, Iwatsubo T, Nochlin D, Sumi SM, Levy-Lahad E, Bird TD. Amyloid (A β) deposition in chromosome 1 linked Alzheimer disease: the Volga German families. Ann Neurol 1997; 41: 52-7
106. 106 Mantyh PW, Ghilardi JR. Rogers S et al. Aluminium, Iron, and Zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J Neurochem 1993; 61: 1171-4
107. 107 Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci 1997; 17: 1046-54
108. 108 Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down Syndrome. Proc Natl Acad Sci USA 1985 82: 4245-9
109. 109 Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to exictotoxicity. J Neurosci 1992; 12: 376-89
110. 110 Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 1993; 10: 243-54
111. 111 McKenzie JE, Gentleman SM, Roberts GW, Graham DI, Royston MC. Increased numbers of bAPP-immunoreactive neurones in the entorhinal cortex after head injury. Neuroreport 1994; 6: 161-4
112. 112 Meda L, Cassatella MA, Szendrei GI et al. Activalion of microglial cells by β-amyloid protein and interferon-γ. Nature 1995; 374: 647-50
113. 113 Miller DL, Papayannopoulos IA, Styles J et al. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 1993; 301: 41-52
114. 114 Mills J, Laurent Charest D, Lam F et al. Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway. J Neurosci 1997; 17: 9415-22
115. 115 Milward EA, Papadopoulos R, Fuller SJ et al. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 1992; 9: 129-37
116. 116 Miyata M, Smith JD. Apolipoprotein E allele-specific anti-oxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 1996; 14: 55-61
117. 117 Motter R, Vigo-Pelfrey C, Kholodenko D et al. Reduction of β-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzhiemer's disease. Ann Neurol 1995; 38: 643-8
118. 118 Mucke L, Masliah E, Johnson WB et al. Synaptotrophic effects of human amyloid b protein precursors in the cortex of transgenic mice. Brain Res 1994; 666: 151-67
119. 119 Mucke L, Abraham CR, Ruppe MD et al. Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein. J Exp Med 1995; 181: 155 1-6
120. 120 Mullan M, Crawford F, Axelman K et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genet 1992; 1: 345-7
121. 121 Multhaup G. Identification and regulation of the high affinity binding site of the Alzheimer's disease amyloid protein precursor (APP) to glycosaminoglycans. Biochimie 1994; 76: 304-11
122. 122 Multhaup G, Bush AI, Pollwein P, Masters CL. Interaction between the zinc (II) and the heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP). FEBS Lett 1994; 355: 151-4
123. 123 Multhaup G, Schlicksupp A, Hesse L et al. The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I). Science 1996; 271: 1406-9
124. 124 Multhaup G, Ruppert T, Schlicksupp A et al. Copper-binding amyloid precursor protein undergoes a site-speciifc fragmentation in the reduction of hydrogen peroxide. Biochemistry 1998; 37: 7224-30
125. 125 Nakamura Y, Takeda M, Niigawa H, Hariguchi S, Nishimura T. Amyloid β-protein precursor deposition in rat hippocampus lesioned by ibotenic acid injection. Neurosci Letts 1992; 136: 95-8
126. 126 Napolitano G, Palka G, Grimaldi S et al. Growth delay in Down syndrome and zinc sulphate supplementation. Am J Med Genet Suppl 1990; 7: 63-5
127. 127 Narindrasorasak S, Lowery DE, Altman RA, Gonzalez DeWhitt PA, Greenberg BD, Kisilevsky R. Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins. Lab Invest 1992; 67: 643-52
128. 128 Nitsch RM, Growdon JH. Role of neurotransmission in the regulation of amloid β-protein precursor processing. Biochem Pharmacol 1994; 47: 1275-84
129. 129 Nitsch RM, Slack BE, Wurtman RJ, Growdon JH. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 1992; 258: 304-7
130. 130 Niwano H, Embury PB, Greenberg BD, Ratnoff OD. Inhibitory action of amyloid precursor protein against human Hageman factor (factor XII). J Lab Clin Med 1995; 125: 251-6
131. 131 Oltersdorf T, Fritz LC, Schenk DB et al. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature 1989; 341: 144-7
132. 132 Paganetti PA, Lis M, Klafki HW, Staufenbiel M. Amyloid precursor protein truncated at any of the gamma-secretase sites is not cleaved to β-amyloid. J Neurosci Res 1996; 46: 283-93
133. 133 Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 1991; 563: 311-4
134. 134 Pike CJ, Walencewics-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW. Structure-activity analysis of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J Neurochem 1995; 64: 253-65
135. 135 Roch JM, Shapiro IP, Sundsmo MP et al. Bacterial expression, purification, and functional mapping of the amyloid beta/A4 protein precursor. J Biol Chem 1992; 267: 2214-21
136. 136 Rogaev EI, Sherrington R, Rogaeva EA et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995; 376: 775-8
137. 137 Rogers J, Webster S, Lue LF et al. Inflammation and Alzheimer's disease pathogenesis. Neurobiol Aging 1996; 17: 681-6
138. 138 Roher AE, Lowenson JD, Clarke S et al. Structural altertions in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 1993; 268: 3072-83
139. 139 Rosen DR, Martin-Morris L, Luo LQ, White K. A Drosophila gene encoding a protein resembling the human beta-amyloid protein precursor. Proc Natl Acad Sci USA 1989; 86: 2478-82
140. 140 Rosenberg RD, Bauer KA, Marcum JA. Protease inhibitors of human plasma. Antithrombin-III. 'The heparin-antithrombin system'. J Med 1985; 16: 351-416
141. 141 Sahasrabudhe SR, Spruyt MA, Muenkel HA, Blume AJ, Vitek MP, Jacobsen JS. Release of amino-terminal fragments from amyloid precursor protein reporter and mutated derivatives in cultured cells. J Biol Chem 1992; 267: 25602-8
142. 142 Saitoh T, Sundsmo M, Roch JM et al. Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts. Cell 1989; 58: 615-22
143. 143 Sambamurti K, Shioi J, Anderson JP, Pappolla MA, Robakis NK. Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells. J Neurosci Res 1992; 33: 319-29
144. 2/APPH). two amino acids length difference to human and murine homologues. Biochim Biophys Acta 1994 ;1219: 167-70
145. 145 Saporito-Irwin SM, Van-Nostrand WE. Coagulation factor XIa cleaves the RDHS sequence and abolishes the cell adhesive properties of the amyloid ïïb-protein. J Biol Chem 1995; 270: 26265-9
146. 146 Savory J, Exley C, Forbes WF et al. Can the controversy of the role of aluminium in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to he considered? J Toxicol Environ Health 1996; 48: 615-35
147. 147 Scandura JM, Zhang Y, Van Nostrand WE, Walsh PN. Progress curve analysis of the kinetics with which blood coaggulation factor XIa is inhibited by protease nexin-2. Biochemistry 1997; 36: 412-20
148. 148 Scheuner D, Eckman C, Jensen M et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med 1996; 2: 864-70
149. 149 Schmaler AH, Dahl LD, Rozemuller AJ et al. Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa. J Clin Invest 1993; 92: 2540-5
150. 150 Schrader-Fischer G, Paganetti PA. Effect of alkalizing agents on the processing of the β-amyloid precursor protein. Brain Res 1996; 716: 91-100
151. 151 Schubert D, LaCorbiere M, Saitoh T, Cole G. Characterization of an amyloid beta precursor protein that binds heparin and contains tyrosine sulfate. Proc Natl Acad Sci USA 1989; 86: 2066-9
152. 152 Schubert D, Behl C. The expression of amyloid beta protein precursor protects nerve cells from beta-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix. Brain Res 1993; 629: 275-82
153. 153 Schubert D, Behl C, Lesley R et al. Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci USA 1995; 92: 1989-93
154. 154 Selkoe DJ. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 1994; 10: 373-403
155. 155 Seubert P, Vigo-Pelfrey C, Esch F et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 1992; 359: 325-7
156. 156 Seubert P, Oltersdorf T, Lee MG et al. Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature 1993; 361: 260-3
157. 157 Sherrington R, Froelich S, Sorbi S et al. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet 1996; 5: 985-8
158. 158 Sherrington R, Rogaev EI, Liang Y et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754-60
159. 159 Shivers BD, Hilbich C, Multhaup G, Salbaum M, Beyreuther K, Seeburg PH. Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J 1988; 7: 1365-70
160. 160 Shoji M, Golde TE, Ghiso J et al. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 1992; 258: 126-9
161. 161 Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Seience 1990; 248: 492-5
162. 162 Sisodia SS. Secretion of the beta-amyloid precursor protein. Ann NY Acad Sci 1992; 674: 53-7
163. 163 Slunt HH, Thinakaran G, Lee MK, Sisodia SS. Nucleotide sequence of the chromosome 14-encoded S182 cDNA and revised secondary structure prediction. Amyloid: Int. J Exp Clin Invest 1995; 2: 188-90
164. 164 Small DH, Nurcombe V, Reed G et al. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J Neurosci 1994; 14: 2117-27
165. 165 Smith RP, Higuchi DA, Broze GJ. Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. Science 1990; 248: 1126-8
166. 166 Smith-Swintosky VL, Pettigrew LC, Craddock SD, Culwell AR, Rydel RE, Mattson MP. Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. J Neurochem 1994; 63: 781-4
167. 167 Snow AD, Kinsella MG, Parks E et al. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease. Arch Biochem Biophys 1995; 320: 84-95
168. 168 Soto C, Sigurdsson EM, Morelli L, Kumar RA, Castaño EM, Frangione B. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nature Med 1998; 4: 822-6
169. 169 Sprecher CA, Grant FJ, Grimm G et al. Molecular cloning of the cDNA for a human amyloid precursor protein homolog: evidence for a multigene family. Biochemistry 1993; 32: 4481-6
170. 170 Strittmatter WJ, Saunders AM, Schmechel D et al. Apolipoprotein E. high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 1977-81
171. 171 Suo Z, Fang C, Crawford F, Mullan M. Superoxide free radical and intracellular calcium mediate Aβ (1-42) induced endothelial toxicity. Brain Res 1997; 762: 144-52
172. 172 Suzuki N, Cheung TT, Cai X-D et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP 717) mutants. Science 1994; 264: 133-6
173. 173 Terry RD. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J Neuropathol Exp Neurol 1996; 55: 1023-5
174. 174 Tienari PJ, De Strooper B, Ikonen E et al. The ïïb-amyloid domain is essential for axonal sorting of amyloid precursor protein. EMBO J 1996; 15: 5218-29
175. 175 Tienari PJ, Ida N, Ikonen E et al. Intracellular and secreted Alzheimer beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc Natl Acad Sci USA 1997; 94: 4125-30
176. 176 Tomita T, Maruyama K, Saido TC et al. The presenilin 2 mutation (N14H) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue. Proc Natl Acad Sci USA 1997; 94: 2025-30
177. 177 Turner RS, Suzuki N, Chyung ASC, Younkin SG, Lee VM-Y. Amyloids β40 and β42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. J Biol Chem 1996; 271: 8966-70
178. 178 Van Nostrand WE, Wagner SL, Suzuki M et al. Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid ïïb-protein precursor. Nature 1989; 341: 546-9
179. 179 Van Nostrand WE, Schmaier AH, Farrow JS, Cunningham DD. Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein. Science 1990; 248: 745-8
180. 180 Van Nostrand WE, Schmaier AH, Neiditch BR et al. Expression, purification, and characterization of the Kunitz-type proteinase inhibitor domain of the amyloid ïïb-protein precursor-like protein-2. Biochim Biophys Acta 1994; 1209: 165-70
181. 181 Van Nostrand WE. Zinc (II) selectively enhances the inhibition of coagulation factor XIa by protease nexin-2/amyloid beta-protein precursor. Thromb Res 1995; 78: 43-53
182. 182 Vidal F, Blangy A, Rassoulzadegan M, Cuzin F. A murine sequence-specific DNA binding protein shows extensive local similarities to the amyloid precursor protein. Biochem Biophys Res Commun 1992; 189: 1336-41
183. 183 Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, Schenk DB. Characterization of β-amyloid peptide from human cerebrospinal fluid. J Neurochem 1993; 61: 1965-8
184. 184 Wasco W, Bupp K, Magendantz M, Gusella JF, Tanzi RE, Solomon F. Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor. Proc Natl Acad Sci USA 1992; 89: 10758-62
185. 185 Weidemann A, König G, Bunke D et al. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 1989; 57: 115-26
186. 186 Weidemann A, Paliga K, Durrwang U et al. Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and β-amyloid precursor protein. Nat Med 1997; 3: 328-32
187. 187 Wertkin AM, Turner RS, Pleasure SJ et al. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid precursor protein and produce intracellular β-amyloid or A4 peptides. Proc Natl Acad Sci USA 1993; 90: 9513-7
188. 188 Whyte S, Jones L, Coulson EJ et al. The metabolism of the amyloid precursor protein of Alzheimer's disease and dietary zinc. In: Alzheimer'z Disease. Biology, Diagnosis and Therapeutics, Eds. K Iqbal, B Winblad, T Nishimura, M Takeda, HM Wisniewski, Chichester: John Wiley and Sons Ltd, 1997: 417-22
189. 189 White AR, Zheng H, Galatis D et al. Survival of cultured neurons from APP. knockout mice against Alzheimer's amyloid Aβ toxicity and oxidative stress. J Neurosci 1998; 18: in press
190. 190 Wild-Bode C, Yamazaki T, Capell A et al. Intracellular generation and accumulation of amyloid β-peptide terminating at amino acid 42. J Biol Chem 1997; 272: 16085-8
191. 191 Williamson TG, Mok SS, Henry A et al Secreted glypican binds to the amyloid precursor protein of Alzheimer's disease (APP) and inhibits APP-induced neurite out-growth. J Biol Chem 1996; 271: 31215-21
192. 192 Wisniewski T, Ghiso J. Frangione B. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem Biophys Res Commun 1991; 179: 1247-54
193. 193 Xia W, Zhang J. Perez R, Koo EH, Selkoe DJ. Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease. Proc Natl Natl Sci USA 1997; 94: 8208-13
194. 194 Xu H, Gouras GK, Greenfield JP et al. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nature Med 1998; 4: 447-51
195. 195 Xu H, Sweeney D, Wang R et al. Generation of Alzheimer β-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc Natl Acad Sci USA 1997; 94: 3748-52
196. 196 Yamada T, Sasaki H, Furuya H, Miyata T, Goto I, Sakaki Y. Complementary DNA for the mouse homolog of the human amyloid beta protein precursor. Biochem Biophys Res Commun 1987; 149: 665-71
197. 197 Yan SD, Chen X, Fu J et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 1996; 382: 685-91
198. 198 Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of anyloid β protein: reversal by tachykinin neuropeptides. Science 1990; 250: 279-82
199. 199 Yankner BA. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 1996; 16: 921-32
200. 200 Yurchenco PD, Schittny JC. Molecular architecture of basement membranes. FASEB J 1990; 4: 1577-90
201. 201 Zhao J, Paganini L, Mucke L et al. β-secretase processing of the β-amyloid precursor protein in transgenic mice is efficient in neurons but inefficient in astrocytes. J Biol Chem 1996; 271: 31407-11
202. 202 Zhong Z, Higaki J, Murakami K et al. Secretion of β-amyloid precursor protein involves multiple cleavage sites. J Biol Chem 1994; 269: 627-32